Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
When Escherichia coli was grown in medium containing both inosine and glycine, the PurR repressor protein was shown to be responsible for a twofold reduction from the fully induced glycine cleavage enzyme levels. This twofold repression was also seen by measuring
beta-galactosidase
levels in cells carrying a lambda gcvT-lacZ gene fusion. In this fusion, the synthesis of
beta-galactosidase
is under the control of the
gcv
regulatory region. A DNA fragment carrying the
gcv
control region was shown by gel mobility shift assay and DNase I footprinting to bind purified PurR protein, suggesting a direct involvement of the repressor in
gcv
regulation. A separate mechanism of purine-mediated regulation of
gcv
was shown to be independent of the purR gene product and resulted in an approximately 10-fold reduction of
beta-galactosidase
levels when cells were grown in medium containing inosine but lacking the inducer glycine. This additional repression was dependent upon a functional gcvA gene, a positive activator for the glycine cleavage enzyme system. A dual role for the GcvA protein as both an activator in the presence of glycine and a repressor in the presence of inosine is suggested.
...
PMID:Roles of the GcvA and PurR proteins in negative regulation of the Escherichia coli glycine cleavage enzyme system. 834 52